Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18609087rdf:typepubmed:Citationlld:pubmed
pubmed-article:18609087lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18609087lifeskim:mentionsumls-concept:C0005953lld:lifeskim
pubmed-article:18609087lifeskim:mentionsumls-concept:C0023473lld:lifeskim
pubmed-article:18609087lifeskim:mentionsumls-concept:C2350570lld:lifeskim
pubmed-article:18609087lifeskim:mentionsumls-concept:C0062534lld:lifeskim
pubmed-article:18609087lifeskim:mentionsumls-concept:C0178587lld:lifeskim
pubmed-article:18609087lifeskim:mentionsumls-concept:C0237881lld:lifeskim
pubmed-article:18609087lifeskim:mentionsumls-concept:C0220901lld:lifeskim
pubmed-article:18609087lifeskim:mentionsumls-concept:C0750502lld:lifeskim
pubmed-article:18609087pubmed:issue6lld:pubmed
pubmed-article:18609087pubmed:dateCreated2008-11-12lld:pubmed
pubmed-article:18609087pubmed:abstractTextThe aims of the study were: (1) to perform a complex angiogenic assessment in chronic myeloid leukaemia (CML) patients using multiple parameters: bone marrow microvessel density (MVD), bone marrow immunohistochemical cellular expressions of vascular endothelial growth factor (VEGF) and its receptor KDR, as well as hepatocyte growth factor (HGF) and its receptor MET, and the plasma VEGF and HGF; and (2) to determine the clinical significance of these factors for patients with CML.lld:pubmed
pubmed-article:18609087pubmed:languageenglld:pubmed
pubmed-article:18609087pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18609087pubmed:citationSubsetIMlld:pubmed
pubmed-article:18609087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18609087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18609087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18609087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18609087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18609087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18609087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18609087pubmed:statusMEDLINElld:pubmed
pubmed-article:18609087pubmed:issn1502-7686lld:pubmed
pubmed-article:18609087pubmed:authorpubmed-author:IvanovaLLlld:pubmed
pubmed-article:18609087pubmed:authorpubmed-author:GerchevaLLlld:pubmed
pubmed-article:18609087pubmed:authorpubmed-author:TonchevA BABlld:pubmed
pubmed-article:18609087pubmed:authorpubmed-author:ZhelyazkovaA...lld:pubmed
pubmed-article:18609087pubmed:authorpubmed-author:KolovaPPlld:pubmed
pubmed-article:18609087pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18609087pubmed:volume68lld:pubmed
pubmed-article:18609087pubmed:ownerNLMlld:pubmed
pubmed-article:18609087pubmed:authorsCompleteYlld:pubmed
pubmed-article:18609087pubmed:pagination492-500lld:pubmed
pubmed-article:18609087pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:18609087pubmed:meshHeadingpubmed-meshheading:18609087...lld:pubmed
pubmed-article:18609087pubmed:meshHeadingpubmed-meshheading:18609087...lld:pubmed
pubmed-article:18609087pubmed:meshHeadingpubmed-meshheading:18609087...lld:pubmed
pubmed-article:18609087pubmed:meshHeadingpubmed-meshheading:18609087...lld:pubmed
pubmed-article:18609087pubmed:meshHeadingpubmed-meshheading:18609087...lld:pubmed
pubmed-article:18609087pubmed:meshHeadingpubmed-meshheading:18609087...lld:pubmed
pubmed-article:18609087pubmed:meshHeadingpubmed-meshheading:18609087...lld:pubmed
pubmed-article:18609087pubmed:meshHeadingpubmed-meshheading:18609087...lld:pubmed
pubmed-article:18609087pubmed:meshHeadingpubmed-meshheading:18609087...lld:pubmed
pubmed-article:18609087pubmed:meshHeadingpubmed-meshheading:18609087...lld:pubmed
pubmed-article:18609087pubmed:meshHeadingpubmed-meshheading:18609087...lld:pubmed
pubmed-article:18609087pubmed:meshHeadingpubmed-meshheading:18609087...lld:pubmed
pubmed-article:18609087pubmed:meshHeadingpubmed-meshheading:18609087...lld:pubmed
pubmed-article:18609087pubmed:meshHeadingpubmed-meshheading:18609087...lld:pubmed
pubmed-article:18609087pubmed:meshHeadingpubmed-meshheading:18609087...lld:pubmed
pubmed-article:18609087pubmed:meshHeadingpubmed-meshheading:18609087...lld:pubmed
pubmed-article:18609087pubmed:meshHeadingpubmed-meshheading:18609087...lld:pubmed
pubmed-article:18609087pubmed:year2008lld:pubmed
pubmed-article:18609087pubmed:articleTitlePrognostic significance of hepatocyte growth factor and microvessel bone marrow density in patients with chronic myeloid leukaemia.lld:pubmed
pubmed-article:18609087pubmed:affiliationDepartment of Clinical Haematology, University Hospital St. Marina Varna, Varna University of Medicine, Varna, Bulgaria. azhelyazkova@gmail.comlld:pubmed
pubmed-article:18609087pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18609087pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed